Comparing the current results to its competitors, Stereotaxis Inc reported Revenue decrease in the 2 quarter 2026 year on year by -10.6 %, despite the revenue increase by the most of its competitors of 8.52 %, recorded in the same quarter.
March 4, 2024
Stereotaxis Submits Regulatory Applications for Innovative MAGiC Ablation Catheter in Europe and the United StatesStereotaxis, a renowned pioneer and a global leader in surgical robotics for minimally invasive endovascular intervention, has recently announced the submission of regulatory applications for its groundbreaking MAGiC Ablation Catheter in both Europe and the United States. This significant development follows the success of the initial clinical results obtained from an ongoing trial.The MAGiC Ablation Catheter is a revolutionary technology designed to enhance precision and efficiency during minimally invasive surgical procedures involving endovascular intervention. This innovative catheter, integ...
January 8, 2024
:This article presents a comprehensive review of the recent advancements in catheter ablation technology, with a focus on the groundbreaking Magnetic Interventional Catheter (MAGiC) developed by Stereotaxis. The primary objective is to explore the efficacy and safety of MAGiC in the treatment of cardiac arrhythmias. Through a detailed analysis of the recent study conducted by Stereotaxis and the successful treatment outcomes of the first patients with MAGiC, this article highlights its potential in revolutionizing the field of interventional cardiology.Catheter ablation is an established and effective treatment strategy for various cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, ...
Atricure Inc is a medical device company that focuses on developing, manufacturing, and selling innovative surgical solutions for the treatment of cardiac arrhythmias and other heart-related conditions.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Electromed Inc operates under a business model where they design, manufacture, and market medical devices that provide airway clearance therapy to patients suffering from various respiratory conditions, helping them improve their quality of life. The company focuses on leveraging their expertise in respiratory care and collaborating with healthcare professionals to deliver effective and innovative solutions to their customers.
Sources:
Stereotaxis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Stereotaxis Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
